(Q30352512)

20 June 2017

title

Anti-SARS coronavirus agents: a patent review (2008 - present). (English)

1 reference

20 June 2017

0 references

1 reference

Vathan Kumar

1

0 references

author name string

Young-Sik Jung

series ordinal

2

1 reference

20 June 2017

Po-Huang Liang

series ordinal

3

1 reference

20 June 2017

language of work or name

English

0 references

publication date

2 August 2013

1 reference

Expert Opinion on Therapeutic Patents

20 June 2017

published in

1 reference

20 June 2017

volume

23

1 reference

20 June 2017

issue

10

1 reference

20 June 2017

page(s)

1337-1348

1 reference

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

A novel coronavirus associated with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

A major outbreak of severe acute respiratory syndrome in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Coronavirus as a possible cause of severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Aetiology: Koch's postulates fulfilled for SARS virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Mechanisms and enzymes involved in SARS coronavirus genome expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Viral replicase gene products suffice for coronavirus discontinuous transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Envelope glycoprotein interactions in coronavirus assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Evidence of the recombinant origin of a bat severe acute respiratory syndrome (SARS)-like coronavirus and its implications on the direct ancestor of SARS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Bats are natural reservoirs of SARS-like coronaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

The severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Human coronavirus NL63: a clinically important virus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Characterization and inhibition of SARS-coronavirus main protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Drug design targeting the main protease, the Achilles' heel of coronaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Development of chemical inhibitors of the SARS coronavirus: viral helicase as a potential target

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

The spike protein of SARS-CoV--a target for vaccine and therapeutic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Progress in computational approach to drug development against SARS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Mechanism of the maturation process of SARS-CoV 3CL protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Deubiquitination in virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Letter: New enterovirus type associated with epidemic of aseptic meningitis and-or hand, foot, and mouth disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Chemotherapy of rhinovirus colds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Mechanism of nucleic acid unwinding by SARS-CoV helicase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

The severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class of 5' to 3' viral helicases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Development of a chimeric DNA-RNA hammerhead ribozyme targeting SARS virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Ezrin interacts with the SARS coronavirus Spike protein and restrains infection at the entry stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Studies of bioactivity, conformation and pharmacokinetic profiles of site-specific PEGylated thymosin alpha 1 derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Novel five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Achieving a golden mean: mechanisms by which coronaviruses ensure synthesis of the correct stoichiometric ratios of viral proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Differential inhibitory activities and stabilisation of DNA aptamers against the SARS coronavirus helicase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Isolation of inhibitory RNA aptamers against severe acute respiratory syndrome (SARS) coronavirus NTPase/Helicase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.823159

10.1517/13543776.2013.823159

21 January 2018

Identifiers

DOI

1 reference

20 June 2017

1 reference